FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,846,470 | -55.0% | 183,000 | 0.0% | 0.36% | -55.8% |
| Q3 2022 | $4,101,000 | -9.6% | 183,000 | 0.0% | 0.81% | -11.6% |
| Q2 2022 | $4,535,000 | -39.4% | 183,000 | -5.3% | 0.91% | -31.2% |
| Q1 2022 | $7,489,000 | -33.7% | 193,160 | 0.0% | 1.33% | -21.9% |
| Q4 2021 | $11,302,000 | -1.3% | 193,160 | 0.0% | 1.70% | +78.7% |
| Q3 2021 | $11,449,000 | -10.3% | 193,160 | +31.4% | 0.95% | -7.8% |
| Q2 2021 | $12,758,000 | +8.6% | 147,000 | +3.2% | 1.03% | +15.8% |
| Q1 2021 | $11,749,000 | +30.5% | 142,500 | +43.9% | 0.89% | +40.5% |
| Q4 2020 | $9,002,000 | – | 99,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |